Gene · 4607
NIH grants2,246
NIH grants whose papers are about the gene, through NIH's grant-paper links.
241 to 260 of 2,246
Download this page as JSON| Grant | Title | MYBPC3 papers | Newest fiscal year |
|---|---|---|---|
| R01HL152446 | Branched chain amino acids in heart failure | 1 | 2025 |
| R01HL155197 | Probing Phenotype-Genotype Relations After Whole Genome Sequencing in Patients with Atrial Fibrillation | 1 | 2025 |
| R01HL155282 | An integrated human stem cell model for elucidating myocardial-endocardial interactions in cardiac development and disease | 1 | 2025 |
| R01HL156670 | Targeting Mitochondria in Single Ventricle Heart Disease | 1 | 2025 |
| R01HL158634 | Signaling To and From the Vascular/Endothelial Compartment and Progression of HCM Linked to Sarcomere Mutations | 1 | 2025 |
| R01HL159094 | Biomaterial Platforms to Model the Role of Mechanical Overload in MYBPC3-Linked Hypertrophic Cardiomyopathy | 1 | 2025 |
| R01HL161045 | The methyltransferase Smyd1 regulates cardiac physiology | 1 | 2025 |
| R01HL163277 | Cardiac fibroblast inflammasome and atrial myopathy | 1 | 2025 |
| R01HL163977 | Data-driven optimization of therapy for heart failure | 1 | 2025 |
| R01HL163987 | Deep Mutational Scanning and Functional Analysis of Repolarization Determinants | 1 | 2025 |
| R01HL164013 | Engineering Human Heart Tissues with Polyploid Cardiomyocytes | 1 | 2025 |
| R01HL164520 | Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sex | 1 | 2025 |
| R01HL164560 | Structural basis of the super-relaxed state in human cardiac muscle | 1 | 2025 |
| R01HL165241 | Optogenetic regulation of intra-ciliary calcium signaling in cardiac situs development | 1 | 2025 |
| R01HL167072 | Imaging and multi-omics analyses to identify molecular subtypes of distinct emphysema patterns | 1 | 2025 |
| R01HL168059 | Pathogenic hotspots illuminate mechanism and therapeutic potential in arrhythmogenic cardiomyopathy | 1 | 2025 |
| R01HL168382 | Transcriptomics, pathobiology, and cardiac event in hypertrophic cardiomyopathy | 1 | 2025 |
| R01HL168841 | Risk Alleles in Protein Quality Control Genes as Modifiers of Hypertrophic Cardiomyopathy | 1 | 2025 |
| R01HL169458 | Methods for Enhancing Polygenic Risk Prediction Models for Complex Disease | 1 | 2025 |
| R01HL171657 | Thick filament regulation mechanisms in healthy and diseased myocardium | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/grants?page=13